Peptides: From Bodybuilder Forums to Mainstream Wellness Craze
Peptides, which are short chains of amino acids, have surged in popularity, moving from niche bodybuilder discussions to broader social media platforms. Marketed under names such as BPC-157 and GHK-Cu, these compounds claim to offer advantages like muscle recovery and weight loss. Although insulin has been an essential treatment since the 1920s, many peptides lack FDA approval and are marked 'for research use only.' Experts like Deborah Doroshow from Mount Sinai caution that these substances are 'completely untested and unregulated.' A survey revealed that nearly half of over 500 doctors reported having patients utilizing experimental peptides. As of May, related hashtags on Instagram had amassed over 130,000 posts and 230 million views on TikTok. Potential dangers include kidney damage and liver failure. Health Secretary Robert F. Kennedy Jr. endorses peptides.
Key facts
- Peptides are short chains of amino acids that carry instructions to cells.
- Many peptides sold online are experimental, not FDA-approved, and sold with 'for research use only' disclaimers.
- GLP-1 drugs like Ozempic helped bring peptides into the mainstream.
- A survey of over 500 physicians found nearly half had a patient disclose using an experimental peptide in the past year.
- As of May, peptide-related hashtags had over 130,000 Instagram posts and 230 million TikTok views.
- Insulin, first used in the 1920s, was the first peptide medication.
- The Covid-19 pandemic accelerated the rise of do-it-yourself medicine and eroded trust in health authorities.
- In July, an FDA advisory committee moved to make six peptides easier to access, despite lacking approval.
- Health secretary Robert F. Kennedy Jr. has publicly endorsed peptides.
- Risks include kidney injury, liver failure, and severe allergic reactions.
Entities
Institutions
- Food and Drug Administration
- Mount Sinai
- Harvard University
- University of Lincoln
- Cambridge Health Alliance
- Harvard Medical School
- Centers for Disease Control and Prevention
- Commonwealth Fund
- National Academies of Science, Engineering and Medicine
- American Association for the Advancement of Science
Locations
- New York
- United States
- England
- Massachusetts
- Washington, D.C.